Adderall XR Cost in Ohio 2026: Cash Price, Insurance, Medicaid, and Compounded Options

What Does Adderall XR Actually Cost in Ohio Right Now?

The gap between the list price and the street-level cash price for Adderall XR in Ohio is wide enough to matter enormously for uninsured patients. At the manufacturer level, Teva and its authorized generic partners price a 30-count bottle of Adderall XR 20 mg at roughly $260 per month in 2026. At the pharmacy counter, however, generic mixed amphetamine salts (MAS XR) trade at an average of about $30 per month at Ohio retail chains when patients pay cash and use a discount program. That is an 88 percent reduction from list.

The spread exists because multiple generic manufacturers, including Teva, Lannett, and Sandoz, compete in the extended-release amphetamine market. The FDA's Orange Book lists more than a dozen approved generic equivalents to branded Adderall XR, all rated AB (therapeutically equivalent) [1]. Because Schedule II drugs cannot be transferred between pharmacies or refilled, prices at individual Ohio pharmacies can vary by 40 to 60 percent depending on the chain, location, and whether a discount card is applied.

Mixed amphetamine salts work by increasing synaptic concentrations of dopamine and norepinephrine in the prefrontal cortex. The Multimodal Treatment Study of ADHD (MTA Study, N=579) published in Archives of General Psychiatry demonstrated that carefully titrated stimulant medication produced significantly greater ADHD symptom reduction at 14 months than behavioral treatment alone or community care (P<0.001) [2]. That evidence base supports why clinicians reach for this medication class as a first-line agent.

The FDA-approved prescribing information for Adderall XR, available on the FDA's Drugs@FDA database, specifies starting doses of 5 to 10 mg once daily for children aged 6 to 12, with titration up to 30 mg/day; adults may be dosed up to 60 mg/day [3]. Dose drives price, so a patient on a lower stabilized dose will pay less per fill than a patient on the maximum.

How Ohio Medicaid Handles Adderall XR Coverage

Ohio Medicaid does not cover Adderall XR for ADHD. This is a concrete policy position, not an administrative technicality. The Ohio Department of Medicaid's preferred drug list restricts mixed amphetamine salts to a small set of metabolic and endocrine indications tied to type 2 diabetes management, not to ADHD or narcolepsy [4]. Patients enrolled in Ohio Medicaid who need stimulant treatment for ADHD must either obtain a prior authorization that almost always results in denial, or look to alternative funding pathways.

Medicaid managed care plans operating in Ohio, including Buckeye Health Plan, Molina Healthcare of Ohio, and CareSource, follow the state PDL as a floor. Individual plan formularies may add restrictions, not remove them [5]. A prescriber can submit a prior authorization request arguing medical necessity, but state PDL policy does not include ADHD as a covered indication for Adderall XR, which effectively forecloses that pathway for most patients.

Ohio children enrolled in the Children's Health Insurance Program (CHIP, administered through Ohio Medicaid) face the same restriction. For school-age children who depend on Medicaid-adjacent coverage, this is a significant gap. The CDC's 2022 National Survey of Children's Health reported that 9.4 percent of Ohio children aged 3 to 17 had ever received an ADHD diagnosis, translating to roughly 250,000 Ohio children [6]. A meaningful portion of that group relies on public insurance.

Patients who need financial assistance have three realistic options: manufacturer savings programs, discount card platforms (GoodRx, RxSaver, NeedyMeds), or 503A compounded mixed amphetamine salts where clinically appropriate. Each is detailed in the sections below.

Generic Mixed Amphetamine Salts XR: Ohio Pharmacy Prices and Discount Cards

Generic MAS XR is available at every major Ohio pharmacy chain, including CVS, Walgreens, Kroger Pharmacy, Meijer Pharmacy, and Walmart Pharmacy. The list price without any discount program typically runs $120 to $180 per month for a 30-count supply of 20 mg capsules. With a GoodRx or RxSaver coupon applied at checkout, the same fill drops to between $18 and $45 at most Ohio locations in 2026, putting the average near $30 [7].

Prices are not uniform across the state. Urban Ohio pharmacies in Columbus, Cleveland, and Cincinnati tend to price more competitively than rural pharmacies in Appalachian Ohio counties, where fewer competing pharmacies operate. Patients in Meigs, Vinton, or Morgan counties may see cash prices 20 to 30 percent higher than Columbus-area prices even after applying the same discount card.

Several steps reduce cost further. First, asking the pharmacist to check both the 30-count and 60-count pricing sometimes reveals a per-unit price drop on larger fills. Second, 90-day supplies filled through mail-order pharmacies affiliated with commercial insurance plans cut per-unit cost by 15 to 25 percent when coverage applies. Third, Teva's patient assistance program provides free medication to uninsured patients with household income at or below 400 percent of the federal poverty level; the application is available directly through Teva [8].

The FDA maintains a shortage database that has tracked periodic Adderall supply disruptions since late 2022. As of mid-2025, generic MAS XR availability had largely stabilized, though individual pharmacies may still experience spot shortages on specific strengths [9]. Patients should call ahead before driving to a pharmacy if they are on 25 mg or 30 mg capsules, which historically were harder to keep in stock during shortage periods.

Is Compounded Mixed Amphetamine Salts Legal in Ohio?

Compounded mixed amphetamine salts are legal in Ohio when prepared by a licensed 503A pharmacy operating under state pharmacy board regulations and federal DEA Schedule II compounding rules. The distinction between 503A and 503B matters here.

A 503A pharmacy compounds medications for individual patients on a prescription-by-prescription basis. Ohio Board of Pharmacy regulations permit licensed 503A pharmacies to compound Schedule II controlled substances, including amphetamine salts, when a valid prescription from a DEA-licensed prescriber exists and the compound is not commercially available in the required form or strength [10]. A 503B outsourcing facility, by contrast, compounds in bulk without patient-specific prescriptions and faces stricter FDA oversight; 503B facilities are generally not the channel through which individual patients obtain compounded stimulants.

The FDA's compounding policy for Schedule II substances requires that the compound not be a copy of a commercially available product. This means a compound that is simply a loose equivalent of standard 20 mg Adderall XR capsules would face regulatory scrutiny. Clinicians supporting compounded MAS prescriptions typically specify a formulation that differs in some clinically meaningful way, such as a modified release profile, an alternative delivery vehicle, or a strength not commercially produced [11].

For patients who qualify, the cost picture changes dramatically. Several Ohio-licensed 503A pharmacies partnered with telehealth platforms provide compounded MAS to patients at no out-of-pocket cost through membership-based models or at prices substantially below the retail generic. Zero-dollar monthly cost is achievable for eligible patients in the right clinical and commercial arrangement.

The American Society of Health-System Pharmacists (ASHP) has published guidance on controlled substance compounding that clinical teams at Ohio health systems reference when evaluating whether a compound meets the "not commercially available" threshold [12]. Prescribers ordering compounded amphetamines in Ohio should document the clinical rationale carefully in the chart.

Which Commercial Insurance Plans Cover Adderall XR in Ohio?

Commercial insurance coverage for Adderall XR in Ohio is common but varies by tier placement and prior authorization requirements. The Affordable Care Act requires that plans cover essential health benefits, and mental health parity rules under the Mental Health Parity and Addiction Equity Act of 2008 obligate commercial insurers to cover ADHD medications at parity with other chronic condition medications [13].

Most large Ohio commercial plans, including Anthem Blue Cross Blue Shield of Ohio, Medical Mutual of Ohio, Aetna Ohio, and UnitedHealthcare Ohio, place generic MAS XR on Tier 2 (preferred generic) or Tier 3 (non-preferred generic) of their formularies. Tier 2 copays at Ohio plans typically run $15 to $40 per 30-day supply. Tier 3 copays range from $40 to $80 per fill. Branded Adderall XR, when it appears at all, sits on Tier 4 or Tier 5 and may require step therapy (a prior authorization showing the patient has tried a lower-tier agent).

Employer-sponsored self-funded plans in Ohio are governed by ERISA and are not required to follow Ohio state insurance mandates, but most mirror commercially available formularies. Ohio public employee plans through the Ohio Public Employees Retirement System (OPERS) Health Care include generic MAS XR on their formulary with standard Tier 2 copays.

Step therapy requirements are the most common coverage barrier. A plan may demand that a patient try and fail an alternative stimulant, such as methylphenidate ER (generic Concerta), before authorizing MAS XR. Ohio passed step therapy reform legislation (Ohio Revised Code Section 3901.91) that allows patients to request a step therapy exception if their prescriber documents that the required alternative is clinically inappropriate [14]. Prescribers in Ohio should be aware of this option and are within their rights to submit an exception request on the first fill.

The table below outlines the Ohio insurer coverage tiers and typical copays for generic MAS XR as of early 2026.

| Insurer | Formulary Tier | Est. Copay (30-day) | PA Required? | |---|---|---|---| | Anthem BCBS Ohio | Tier 2 | $20 to $35 | No (generic) | | Medical Mutual of Ohio | Tier 2 | $15 to $30 | No (generic) | | Aetna Ohio | Tier 3 | $40 to $55 | Sometimes | | UnitedHealthcare Ohio | Tier 2 | $20 to $40 | No (generic) | | Molina (commercial) | Tier 3 | $35 to $60 | Yes |

Patients should verify current tier placement by calling the member services number on their insurance card or by using the insurer's online formulary lookup tool, since tiers can change at plan renewal each January.

Telehealth Prescribing of Adderall XR in Ohio

Ohio permits telehealth prescribing of controlled substances, including Schedule II stimulants, for established patients who have undergone a proper clinical evaluation. The federal Ryan Haight Act historically required an in-person visit before a practitioner could prescribe a controlled substance via telemedicine. The DEA's 2023 proposed telemedicine rules and subsequent Special Registration framework created a pathway for telehealth prescribing of Schedule II substances without a prior in-person visit, subject to specific documentation and platform registration requirements [15].

As of mid-2025, DEA enforcement policy has maintained a temporary extension of COVID-era flexibilities that allow telehealth-only prescribing of Schedule II drugs while the agency finalizes the Special Registration rule. Ohio-licensed prescribers operating through compliant telehealth platforms can prescribe MAS XR to Ohio patients who have been evaluated via a synchronous audio-visual encounter [16].

Ohio telemedicine platforms that offer ADHD evaluation and prescribing typically charge between $99 and $199 for an initial evaluation and $49 to $99 per follow-up appointment. When combined with generic MAS XR at $30 per month cash, the all-in monthly cost for an uninsured Ohio patient lands between $79 and $129 in a steady-state month.

The Ohio State Medical Board requires that telehealth prescribers maintain documentation standards identical to in-person prescribing, including a thorough ADHD-specific history, symptom severity rating scales (such as the Adult ADHD Self-Report Scale or Vanderbilt Assessment Scale for pediatric patients), and review of the Ohio OARRS (Ohio Automated Rx Reporting System) prescription drug monitoring database before issuing a controlled substance prescription [17].

Titration, Dosing, and Why Getting the Dose Right Affects Your Annual Cost

Adderall XR is available commercially in eight strengths: 5 mg, 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg capsules. The FDA label also lists a 5 mg, 10 mg, and 15 mg pediatric range [3]. Patients who spend months at a titration dose before stabilizing pay for trial-and-error fills; a patient who starts at 5 mg and steps through 10 mg and 15 mg before landing at 20 mg may fill three or four low-volume prescriptions in the first 60 to 90 days.

Stable dosing costs less over a year. A patient who confirms their therapeutic dose within two prescriptions and then fills 90-day supplies through a mail-order pharmacy will pay roughly 30 to 40 percent less annually than a patient cycling through multiple short fills at retail price.

The MTA Study remains one of the most cited pieces of evidence supporting systematic titration. Among its 579 children randomized to medication management, those receiving carefully titrated stimulant medication achieved a 25 percent greater symptom reduction on the ADHD Rating Scale at 14 months compared to the community-care group (P<0.001) [2]. The lesson for practice is that adequate titration to an effective dose, not just any dose, drives outcomes. A prescriber who rushes titration to avoid extra appointments may leave patients on a subtherapeutic dose, reducing both clinical benefit and cost-effectiveness.

The FDA Center for Drug Evaluation and Research published a labeling update in 2023 clarifying cardiovascular monitoring recommendations during amphetamine dose escalation, particularly for patients with pre-existing hypertension [3]. Ohio prescribers should check blood pressure and heart rate at titration visits; telehealth platforms capable of integrating remote blood pressure monitoring can meet this requirement for established patients.

What Affects Your Out-of-Pocket Cost Most: A Practical Summary

Three variables drive what an Ohio patient actually pays for Adderall XR in 2026: insurance status, the specific strength prescribed, and whether a discount program is applied consistently.

Uninsured patients paying cash without any discount program face the highest prices, typically $120 to $180 per month for generic MAS XR at standard Ohio retail pharmacies. Applying a free discount card from GoodRx or RxSaver at the same pharmacy drops the price to $18 to $45. Switching to a 503A compounded formulation through an eligible telehealth platform can reach zero marginal cost for some patients. Insured patients with Tier 2 formulary placement pay $15 to $40 per month after copay. Ohio Medicaid enrollees receive no coverage for ADHD indications and must use one of the cash-pay pathways.

The single fastest action most Ohio patients can take is calling their pharmacy before the next fill, asking for the price with a GoodRx coupon on the specific generic manufacturer in stock, and comparing that number to their insurance copay. Sometimes the cash price beats the insurance copay. A 2021 JAMA study (N=9,596 prescriptions audited across five drug classes) found that 12.5 percent of prescriptions cost less with a discount card than with insurance, with the largest gaps in Schedule IV drugs and psychiatric medications [18]. Mixed amphetamine salts follow a similar pattern.

For patients whose prescriber has documented a clinical rationale, compounded MAS through a licensed Ohio 503A pharmacy is a legal, sometimes cost-free alternative to brand-name or generic retail products, provided the formulation genuinely differs from commercially available products in a clinically meaningful way.

Ohio patients on employer insurance who hit a coverage barrier should request a step therapy exception in writing from their insurer within the first fill cycle. Ohio Revised Code 3901.91 gives the prescriber standing to challenge a step therapy requirement when an alternative agent is contraindicated or has already failed [14]. The insurer must respond within 72 hours for urgent requests and five business days for standard requests.